Atlas Trials

A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers

Clinical trial NCT04892875 · WITHDRAWN

Trial details

NCT number
NCT04892875
Sponsor
Jennifer Choe
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Head and Neck CancerSquamous Cell Carcinoma of Head and NeckOral Cavity Squamous Cell CarcinomaOral Cavity CancerOropharynx CancerOropharynx Squamous Cell CarcinomaLarynx CancerPharynx CancerHypopharynx CancerHypopharynx Squamous Cell Carcinoma
Start date
2023-12-31
Primary completion
2025-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.